Mylan, Novartis Settle Spat Over Femara Generic
pharmiweb.co.uk
03-Dec-2008 21 related
        

Law360, New York (December 02, 2008) -- Novartis Pharmaceutical Corp. has ended its battle with generic-drug maker Mylan Inc. over the patent for the generic version of Novartis' Femara, a drug that treats breast cancer in postmenopausal women, by agreeing to provide Mylan with... [read full story]                    

Add Comment
There are also 21 related articles
View all news articles about*:
Cancer Corporate Female Health Hormone Industrial Intellectual Issues Laboratories Legal Medicines Mylan Novartis Patents Pharmaceuticals Property Remedies Therapy Treatments
*Newstin tag cloud displays all featured persons, associated organisations, related topics, regions and companies

View other selected articles:

                   

MSC is graduates’ flexible friend

worksmanagement.co.uk
19 mins ago
        

The first graduates from The Manufacturing Institute’s MSC in Manufacturing Leadership celebrated success when they were awarded their degrees last month by mountaineer Sir Chris Bonnington, Chancellor of Lancaster University.

add comment
                   

U.S. FDA staff backs CSL, GTC blood clot drugs

pharmiweb.co.uk
23 mins ago 4 related
        

By Susan Heavey and Lisa Richwine WASHINGTON (Reuters) - Two proposed therapies to treat rare blood disorders appear safe and effective for U.S. approval, Food and Drug Administration staff reviewers said in documents released...

add comment